Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia

Clinical trial NCT03418038 · RECRUITING

Trial details

NCT number: NCT03418038
Sponsor: Mayo Clinic
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Clonal Cytopenia of Undetermined Significance High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements Recurrent Diffuse Large B-Cell Lymphoma Recurrent Hodgkin Lymphoma Recurrent Lymphoma Refractory Diffuse Large B-Cell Lymphoma Refractory Lymphoma Chronic Myelomonocytic Leukemia

Start date: 2018-03-23
Primary completion: 2031-02-22
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.